KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Current Deferred Revenue (2016 - 2025)

Resmed (RMD) has disclosed Current Deferred Revenue for 16 consecutive years, with $176.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue rose 12.49% year-over-year to $176.0 million, compared with a TTM value of $176.0 million through Dec 2025, up 12.49%, and an annual FY2025 reading of $166.0 million, up 8.83% over the prior year.
  • Current Deferred Revenue was $176.0 million for Q4 2025 at Resmed, up from $167.8 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $176.0 million in Q4 2025 and bottomed at $105.3 million in Q1 2021.
  • Average Current Deferred Revenue over 5 years is $138.2 million, with a median of $143.9 million recorded in 2023.
  • The sharpest move saw Current Deferred Revenue dropped 3.85% in 2022, then soared 35.61% in 2023.
  • Year by year, Current Deferred Revenue stood at $111.6 million in 2021, then increased by 19.94% to $133.9 million in 2022, then grew by 11.19% to $148.9 million in 2023, then rose by 5.11% to $156.5 million in 2024, then grew by 12.49% to $176.0 million in 2025.
  • Business Quant data shows Current Deferred Revenue for RMD at $176.0 million in Q4 2025, $167.8 million in Q3 2025, and $166.0 million in Q2 2025.